SIRT Insider Trading Activity and SEC Form 4 Filings
SIRT insider trading summary
No open-market insider purchases or sales of Sirtris Pharmaceuticals, Inc. (SIRT) have been reported on SEC Form 4 in the past 12 months.
Latest SIRT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Apr 11, 2008 | David Sinclair | Director | Sell | $5K (400 @ $12.97) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $11K (800 @ $13.43) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $5K (400 @ $12.93) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $8K (600 @ $12.94) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $5K (400 @ $13.41) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $4K (300 @ $13.05) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $9K (700 @ $13.09) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $3K (229 @ $13.40) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $9K (700 @ $13.42) |
| Apr 11, 2008 | David Sinclair | Director | Sell | $8K (600 @ $12.92) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.